Whereas normal breast tissues have high levels of RPA1 expression, the nuclear RPA3 level was significantly reduced in DCIS and invasive breast cancers (P < 0.0001, Fig. 3A, B). Here, RPA3 is linked to ductal breast carcinoma in situ.